Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain injury
Type
Journal articleSubject
Science & TechnologyLife Sciences & Biomedicine
Cell & Tissue Engineering
Biotechnology & Applied Microbiology
Cell Biology
Hematology
Medicine, Research & Experimental
Research & Experimental Medicine
Permalink
https://hdl.handle.net/10161/24722Published Version (Please cite this version)
10.1016/j.jcyt.2015.03.503Publication Info
(2015). Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain
injury. Cytotherapy, 17(6). pp. S57-S57. 10.1016/j.jcyt.2015.03.503. Retrieved from https://hdl.handle.net/10161/24722.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Joanne Kurtzberg
Jerome S. Harris Distinguished Professor of Pediatrics
Dr. Kurtzberg is an internationally renowned expert in pediatric hematology/oncology,
pediatric blood and marrow transplantation, umbilical cord blood banking and transplantation,
and novel applications of cord blood and birthing tissues in the emerging fields of
cellular therapies and regenerative medicine. Dr. Kurtzberg serves as the Director
of the Marcus Center for Cellular Cures (MC3), Director of the Pediatric Transplant
and Cellular Therapy Program, Director of the Carolina
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info